NYMXF — Nymox Pharmaceutical Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba
Nymox up on submitting marketing application for lead drug in Europe
Brief: Nymox Announces New Marketing Submission For NYMOZARFEX For BPH
Brief: May 2023 Market Cap Requirement Update
Nymox Pharma rises on plans to resubmit Lead drug marketing application
Brief: Nymox Updates Shareholders
Brief: Nymox Receives Deficiency Letter From Nasdaq
Nymox hits 7-yr low after FDA refuses marketing application of lead drug
NASDAQ RESUMED AT 09:00 AM
Brief: Nymox Receives RTF Letter From FDA
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:25 AM
Brief: Nymox Announces $5 Million Registered Direct Offering
Brief: Nymox Announces Submission Of New Drug Application (NDA) To The FDA For Fexapotide Triflutate
Brief: Nymox Pharmaceutical Completes All Required Tasks For Planned Upcoming Regulatory Submission For Fexapotide Triflutate For Treatment Of BPH
Brief: Nymox Pharmaceutical Corp Files For A Potential Shelf Of Up To $25 Mln Of Common Shares And Debt Securities
Brief: Nymox Pharmaceutical- Main Delayed Vendor Documentation That Was Incomplete Has Been Accomplished